The North American region witnessed a varied price difference in Ritonavir during the second Quarter of 2022. Ritonavir Price increased during the First Half of the Second Quarter due to its raised Upstream Raw material Valine prices. Furthermore, the supply disruption and interrupted export activities from various regions resulted in the price increment of Ritonavir in the overall regional and domestic Market. Towards the second Half of the second quarter, the demand for Ritonavir reduced stiffly, affecting the Market negatively. Further, towards the end of the Second Quarter, the price augmented the demand from various end-user manufacturing enterprises.